EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Association between endocrine therapy and survival outcomes in estrogen receptor–low breast cancer: a systematic review and meta-analysis

Fan Xia, XiaoBo Hu, Lei Zhang, XiaoDong Peng, Mei Xie iD

The Oncologist · 06.06.2026 · 31 (7)

DOI: 10.1093/oncolo/oyag230 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Oncologist, online erschienen am 10.06.2026. Verfasst von Fan Xia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, West China School of Medicine, Sichuan University, Chengdu, 610000, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Estrogen, Antineoplastic Agents, Hormonal. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The clinical significance of endocrine therapy (ET) in patients with estrogen receptor–low (ER-low, 1%-10%) breast cancer remains uncertain. Increasing evidence suggests that these tumors differ biologically from typical hormone receptor–positive cancers, raising questions about the true benefit of ET in this subgroup.

Methods

This systematic review and meta-analysis was conducted in accordance with the PRISMA 2020 guidelines. PubMed, Embase, the Cochrane Library, and Web of Science were searched from inception to July 1, 2025. Hazard ratios (HRs) with corresponding 95% CIs for time-to-event outcomes were extracted directly or estimated from Kaplan–Meier curves when not explicitly reported. Pooled analyses were performed using random-effects models to account for between-study heterogeneity. The protocol was registered in PROSPERO (CRD420251055521).

Results

A total of 6 retrospective observational studies involving 8765 patients with estrogen receptor–low breast cancer were included. Endocrine therapy was associated with improved overall survival (OS) (HR 0.81, 95% CI 0.69-0.95; P = .01; I2 = 0%) and disease-free survival (DFS) (HR 0.64, 95% CI 0.45-0.90; P = .01; I2 = 0%).

Conclusions

Endocrine therapy was associated with improved OS and DFS in patients with estrogen receptor–low breast cancer. These findings suggest that estrogen receptor–low breast cancer should not be uniformly considered endocrine-insensitive and that routine omission of endocrine therapy should be approached cautiously. Given that the available evidence is derived from retrospective observational studies, further prospective studies are needed to identify patients most likely to benefit from endocrine therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsReceptors, EstrogenAntineoplastic Agents, HormonalHumansFemaleDisease-Free Survival

Stichwörter der Autor:innen

ER-lowbreast cancerendocrine therapymeta-analysis

Substanzen

Receptors, EstrogenAntineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Department of Oncology, West China School of Medicine, Sichuan University, Chengdu, 610000, China.
  • Department of Oncology, Sichuan University Affiliated Chengdu Second People's Hospital, Chengdu, 610000, China.
  • Department of Oncology, Chengdu Second People's Hospital, Chengdu, 610000, China.
  • Department of Respiratory and Critical Care Medicine, West China School of Medicine, Sichuan University, Chengdu, 610000, China.
  • Department of Respiratory and Critical Care Medicine, Sichuan University Affiliated Chengdu Second People's Hospital, Chengdu, 610000, China.
  • Department of Respiratory and Critical Care Medicine, Chengdu Second People's Hospital, Chengdu, 610000, China.

ORCID-Profile: Mei Xie

Zitieren

APA

Xia, F., Hu, X., Zhang, L., Peng, X., & Xie, M. (2026). Association between endocrine therapy and survival outcomes in estrogen receptor–low breast cancer: a systematic review and meta-analysis. The Oncologist, 31(7). https://doi.org/10.1093/oncolo/oyag230

Vancouver

Xia F, Hu X, Zhang L, Peng X, Xie M. Association between endocrine therapy and survival outcomes in estrogen receptor–low breast cancer: a systematic review and meta-analysis. The Oncologist. 2026;31(7). doi:10.1093/oncolo/oyag230

BibTeX
@article{Xia2026,
  author = {Xia, Fan and Hu, XiaoBo and Zhang, Lei and Peng, XiaoDong and Xie, Mei},
  title = {Association between endocrine therapy and survival outcomes in estrogen receptor–low breast cancer: a systematic review and meta-analysis},
  journal = {The Oncologist},
  year = {2026},
  volume = {31},
  number = {7},
  doi = {10.1093/oncolo/oyag230}
}
Kostenlos starten →